239 related articles for article (PubMed ID: 11050100)
1. Peroxisome proliferator-activated receptor alpha is not rate-limiting for the lipoprotein-lowering action of fish oil.
Dallongeville J; Baugé E; Tailleux A; Peters JM; Gonzalez FJ; Fruchart JC; Staels B
J Biol Chem; 2001 Feb; 276(7):4634-9. PubMed ID: 11050100
[TBL] [Abstract][Full Text] [Related]
2. Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice.
Peters JM; Hennuyer N; Staels B; Fruchart JC; Fievet C; Gonzalez FJ; Auwerx J
J Biol Chem; 1997 Oct; 272(43):27307-12. PubMed ID: 9341179
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor alpha-mediated pathways are altered in hepatocyte-specific retinoid X receptor alpha-deficient mice.
Wan YJ; Cai Y; Lungo W; Fu P; Locker J; French S; Sucov HM
J Biol Chem; 2000 Sep; 275(36):28285-90. PubMed ID: 10866995
[TBL] [Abstract][Full Text] [Related]
4. Regulation of rat liver apolipoprotein A-I, apolipoprotein A-II and acyl-coenzyme A oxidase gene expression by fibrates and dietary fatty acids.
Berthou L; Saladin R; Yaqoob P; Branellec D; Calder P; Fruchart JC; Denèfle P; Auwerx J; Staels B
Eur J Biochem; 1995 Aug; 232(1):179-87. PubMed ID: 7556148
[TBL] [Abstract][Full Text] [Related]
5. A novel compound that elevates high density lipoprotein and activates the peroxisome proliferator activated receptor.
Bisgaier CL; Essenburg AD; Barnett BC; Auerbach BJ; Haubenwallner S; Leff T; White AD; Creger P; Pape ME; Rea TJ; Newton RS
J Lipid Res; 1998 Jan; 39(1):17-30. PubMed ID: 9469582
[TBL] [Abstract][Full Text] [Related]
6. Paradoxical exacerbation of combined hyperlipidemia in human apolipoprotein A-II transgenic mice treated with fenofibrate.
Ribas V; Palomer X; Roglans N; Rotllan N; Fievet C; Tailleux A; Julve J; Laguna JC; Blanco-Vaca F; Escolà-Gil JC
Biochim Biophys Acta; 2005 Dec; 1737(2-3):130-7. PubMed ID: 16226489
[TBL] [Abstract][Full Text] [Related]
7. Trans-10,cis-12 CLA increases liver and decreases adipose tissue lipids in mice: possible roles of specific lipid metabolism genes.
Warren JM; Simon VA; Bartolini G; Erickson KL; Mackey BE; Kelley DS
Lipids; 2003 May; 38(5):497-504. PubMed ID: 12880104
[TBL] [Abstract][Full Text] [Related]
8. Hypolipidemic activity of select fibrates correlates to changes in hepatic apolipoprotein C-III expression: a potential physiologic basis for their mode of action.
Haubenwallner S; Essenburg AD; Barnett BC; Pape ME; DeMattos RB; Krause BR; Minton LL; Auerbach BJ; Newton RS; Leff T
J Lipid Res; 1995 Dec; 36(12):2541-51. PubMed ID: 8847480
[TBL] [Abstract][Full Text] [Related]
9. Developmental and pharmacological regulation of apolipoprotein C-II gene expression. Comparison with apo C-I and apo C-III gene regulation.
Andersson Y; Majd Z; Lefebvre AM; Martin G; Sechkin AV; Kosykh V; Fruchart JC; Najib J; Staels B
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):115-21. PubMed ID: 9888873
[TBL] [Abstract][Full Text] [Related]
10. Polyunsaturated fatty acid suppression of hepatic fatty acid synthase and S14 gene expression does not require peroxisome proliferator-activated receptor alpha.
Ren B; Thelen AP; Peters JM; Gonzalez FJ; Jump DB
J Biol Chem; 1997 Oct; 272(43):26827-32. PubMed ID: 9341113
[TBL] [Abstract][Full Text] [Related]
11. Fish oil feeding alters liver gene expressions to defend against PPARalpha activation and ROS production.
Takahashi M; Tsuboyama-Kasaoka N; Nakatani T; Ishii M; Tsutsumi S; Aburatani H; Ezaki O
Am J Physiol Gastrointest Liver Physiol; 2002 Feb; 282(2):G338-48. PubMed ID: 11804856
[TBL] [Abstract][Full Text] [Related]
12. Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice.
Duez H; Chao YS; Hernandez M; Torpier G; Poulain P; Mundt S; Mallat Z; Teissier E; Burton CA; Tedgui A; Fruchart JC; Fiévet C; Wright SD; Staels B
J Biol Chem; 2002 Dec; 277(50):48051-7. PubMed ID: 12377786
[TBL] [Abstract][Full Text] [Related]
13. Oxidized frying oil up-regulates hepatic acyl-CoA oxidase and cytochrome P450 4 A1 genes in rats and activates PPARalpha.
Chao PM; Chao CY; Lin FJ; Huang C
J Nutr; 2001 Dec; 131(12):3166-74. PubMed ID: 11739861
[TBL] [Abstract][Full Text] [Related]
14. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
[TBL] [Abstract][Full Text] [Related]
15. Elevated basal expression of liver peroxisomal beta-oxidation enzymes and CYP4A microsomal fatty acid omega-hydroxylase in STAT5b(-/-) mice: cross-talk in vivo between peroxisome proliferator-activated receptor and signal transducer and activator of transcription signaling pathways.
Zhou YC; Davey HW; McLachlan MJ; Xie T; Waxman DJ
Toxicol Appl Pharmacol; 2002 Jul; 182(1):1-10. PubMed ID: 12127257
[TBL] [Abstract][Full Text] [Related]
16. Fibrates suppress fibrinogen gene expression in rodents via activation of the peroxisome proliferator-activated receptor-alpha.
Kockx M; Gervois PP; Poulain P; Derudas B; Peters JM; Gonzalez FJ; Princen HM; Kooistra T; Staels B
Blood; 1999 May; 93(9):2991-8. PubMed ID: 10216095
[TBL] [Abstract][Full Text] [Related]
17. The nuclear receptors peroxisome proliferator-activated receptor alpha and Rev-erbalpha mediate the species-specific regulation of apolipoprotein A-I expression by fibrates.
Vu-Dac N; Chopin-Delannoy S; Gervois P; Bonnelye E; Martin G; Fruchart JC; Laudet V; Staels B
J Biol Chem; 1998 Oct; 273(40):25713-20. PubMed ID: 9748239
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response.
Hennuyer N; Poulain P; Madsen L; Berge RK; Houdebine LM; Branellec D; Fruchart JC; Fiévet C; Duverger N; Staels B
Circulation; 1999 May; 99(18):2445-51. PubMed ID: 10318668
[TBL] [Abstract][Full Text] [Related]
20. Fenofibrate prevents obesity and hypertriglyceridemia in low-density lipoprotein receptor-null mice.
Jeong S; Kim M; Han M; Lee H; Ahn J; Kim M; Song YH; Shin C; Nam KH; Kim TW; Oh GT; Yoon M
Metabolism; 2004 May; 53(5):607-13. PubMed ID: 15131765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
